ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Snowflake Inc

Snowflake Inc (SNOW)

153.83
2.66
( 1.76% )
Updated: 15:02:29

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
153.83
Bid
-
Ask
-
Volume
2,706,605
152.03 Day's Range 155.08
135.26 52 Week Range 237.72
Market Cap
Previous Close
151.17
Open
153.00
Last Trade
1
@
153.83
Last Trade Time
15:02:29
Financial Volume
$ 415,133,553
VWAP
153.378
Average Volume (3m)
7,074,832
Shares Outstanding
329,300,000
Dividend Yield
-
PE Ratio
-60.50
Earnings Per Share (EPS)
-2.54
Revenue
2.81B
Net Profit
-836.1M

About Snowflake Inc

Snowflake delivers the Data Cloud a global network where thousands of organizations mobilize data with near-unlimited scale concurrency and performance. Inside the Data Cloud organizations unite their siloed data easily discover and securely share governed data and execute diverse analytic workloads... Snowflake delivers the Data Cloud a global network where thousands of organizations mobilize data with near-unlimited scale concurrency and performance. Inside the Data Cloud organizations unite their siloed data easily discover and securely share governed data and execute diverse analytic workloads. Wherever data or users live Snowflake delivers a single and seamless experience across multiple public clouds. Snowflakes platform is the engine that powers and provides access to the Data Cloud creating a solution for data warehousing data lakes data engineering data science data application development and data sharing. Join Snowflake customers partners and data providers already taking their businesses to new frontiers in the Data Cloud. Show more

Sector
Prepackaged Software
Industry
Prepackaged Software
Headquarters
Wilmington, Delaware, USA
Founded
1970
Snowflake Inc is listed in the Prepackaged Software sector of the New York Stock Exchange with ticker SNOW. The last closing price for Snowflake was $151.17. Over the last year, Snowflake shares have traded in a share price range of $ 135.26 to $ 237.72.

Snowflake currently has 329,300,000 shares outstanding. The market capitalization of Snowflake is $50.58 billion. Snowflake has a price to earnings ratio (PE ratio) of -60.50.

Snowflake (SNOW) Options Flow Summary

Overall Flow

Bearish

Net Premium

-77M

Calls / Puts

126.83%

Buys / Sells

70.25%

OTM / ITM

129.75%

Sweeps Ratio

0.01%

SNOW Latest News

Snowflake Launches Arctic: The Most Open, Enterprise-Grade Large Language Model

Snowflake (NYSE: SNOW), the Data Cloud company, today announced Snowflake Arctic, a state-of-the-art large language model (LLM) uniquely designed to be the most open, enterprise-grade LLM on the...

Lost Money on Snowflake Inc.(SNOW)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm

Lost Money on Snowflake Inc.(SNOW)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm PR Newswire NEW YORK, April 19, 2024 NEW YORK, April 19, 2024 /PRNewswire/ -- The Gross...

Investors who lost money on Snowflake Inc.(SNOW) should contact The Gross Law Firm about pending Class Action - SNOW

Investors who lost money on Snowflake Inc.(SNOW) should contact The Gross Law Firm about pending Class Action - SNOW PR Newswire NEW YORK, April 16, 2024 NEW YORK, April 16, 2024 /PRNewswire/...

The Gross Law Firm Notifies Snowflake Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - SNOW

The Gross Law Firm Notifies Snowflake Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - SNOW PR Newswire NEW YORK, April 12, 2024 NEW YORK, April 12, 2024 /PRNewswire/ -- The Gross...

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Snowflake Inc.(SNOW) Shareholders

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Snowflake Inc.(SNOW) Shareholders PR Newswire NEW YORK, April 9, 2024 NEW YORK, April 9, 2024 /PRNewswire/ -- The...

Investors in Snowflake Inc. Should Contact The Gross Law Firm Before April 29, 2024 to Discuss Your Rights - SNOW

Investors in Snowflake Inc. Should Contact The Gross Law Firm Before April 29, 2024 to Discuss Your Rights - SNOW PR Newswire NEW YORK, April 5, 2024 NEW YORK, April 5, 2024 /PRNewswire/ -- The...

SNOW LAWSUIT ALERT: The Gross Law Firm Notifies Snowflake Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

SNOW LAWSUIT ALERT: The Gross Law Firm Notifies Snowflake Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire NEW YORK, April 2, 2024 NEW YORK, April 2, 2024 /PRNewswire/...

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 29, 2024 in Snowflake Inc. Lawsuit - SNOW

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 29, 2024 in Snowflake Inc. Lawsuit - SNOW PR Newswire NEW YORK, March 29, 2024 NEW YORK, March 29, 2024 /PRNewswire/...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
12.791.84719279661151.04155.08144.324212841148.20093453CS
4-5.57-3.49435382685159.4165.89144.324843674154.27744775CS
12-47.27-23.505718548201.1237.72144.327074832182.68361921CS
264.733.17236753856149.1237.72138.45981420182.37722484CS
528.986.19951674146144.85237.72135.265687824173.81563569CS
156-81.9-34.7431383362235.73405110.2655500249190.27923752CS
260-91.17-37.212244898245429110.2655283796202.04546132CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.3875
(154.43%)
186.5M
AIREreAlpha Tech Corporation
$ 1.07
(77.15%)
23.69M
BOFBranchOut Food Inc
$ 1.9201
(64.11%)
102.4M
LICNLichen China Limited
$ 0.8766
(56.54%)
13.56M
AMSTAmesite Inc
$ 3.13
(56.50%)
67.02M
NCINeo Concept International Group Holdings Ltd
$ 2.35
(-75.26%)
5.56M
GCTKGlucoTrack Inc
$ 0.48
(-36.84%)
1.45M
EVOEvotec SE
$ 5.21
(-31.90%)
1.43M
VAXXVaxxinity Inc
$ 0.137
(-31.50%)
2.35M
ATXIAvenue Therapeutics Inc
$ 0.0922
(-31.19%)
10.21M
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.3866
(153.84%)
186.5M
TSLATesla Inc
$ 161.1801
(11.40%)
154.91M
SQQQProShares UltraPro Short QQQ
$ 11.8724
(-0.32%)
119M
BOFBranchOut Food Inc
$ 1.9201
(64.11%)
102.4M
AMSTAmesite Inc
$ 3.13
(56.50%)
67.02M

SNOW Discussion

View Posts
WallWeeD WallWeeD 1 month ago
I will wait until after the pullback
👍️0
letsrunthis letsrunthis 2 months ago
why?
👍️0
WallWeeD WallWeeD 2 months ago
Yeah hmm no
👍️0
blue finch blue finch 2 months ago
time to load up here
👍️0
Monksdream Monksdream 2 months ago
SNOW new 52 week high
👍️0
Monksdream Monksdream 2 months ago
SNOW new 52 week high
👍️0
cheynew cheynew 3 months ago
NOVO HOLDINGS TO ACQUIRE CATALENT

Catalent Stockholders to Receive $63.50 Per Share in Cash, Representing a 47.5% Premium to the 60-day Volume-Weighted Average Price as of February 2, 2024

Catalent, Inc. (NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings, a holding and investment company that is responsible for managing the assets and wealth of the Novo Nordisk Foundation, today announced that they have entered into a merger agreement under which Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at $16.5 billion on an enterprise value basis.

Transaction Overview

Novo Holdings will acquire all outstanding shares of Catalent for $63.50 per share in cash. The purchase price represents a premium of 16.5% to the closing price of Catalent’s common stock as of February 2, 2024, the last trading day prior to this announcement, and a 47.5% premium to the 60-day volume-weighted average price as of February 2, 2024.
In addition, the purchase price represents a premium of 39.1% to the closing price of Catalent’s common stock on August 28, 2023, the last trading day prior to Catalent’s announcement that its Board of Directors formed a Strategic and Operational Review Committee to conduct a review of Catalent’s business, strategy and operations, as well as Catalent’s capital-allocation priorities with a view towards maximizing value for all Catalent stockholders.
Of Catalent’s more than 50 global sites, Novo Holdings intends to sell three Catalent fill-finish sites and related assets acquired in the merger to Novo Nordisk (CPH: NOVO), in which Novo Holdings has a controlling interest, shortly after the closing of the merger. These three sites are located in Anagni, Italy; Bloomington, Indiana, USA; and Brussels, Belgium.
This transaction is aligned with Novo Holdings’ strategy of investing in established life science companies with strong long-term potential.
Alessandro Maselli, President and Chief Executive Officer of Catalent, said: “Over the past several years, Catalent has built a comprehensive end-to-end offering of services and capabilities to drive innovation in the healthcare system and improve patient outcomes. This transaction is a testament to our team’s hard work and dedication to this mission, and I am incredibly excited for this next step in our journey. We look forward to benefiting from Novo Holdings’ significant resources to accelerate investment in our business and enhance key offerings as we continue to offer premium development and manufacturing solutions for pharma and biotech customers.”

John Greisch, Executive Chair of the Catalent Board and Chair of the Strategic and Operational Review Committee, said: “This transaction delivers significant, certain and premium value to our stockholders. Novo Holdings believes in our vision and will provide Catalent with a strong foundation as we continue developing, manufacturing and supplying top products.”

Novo Holdings has a proven track record of successfully investing in the life sciences sector. Importantly, Novo Holdings’ purpose is to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation.

Kasim Kutay, CEO of Novo Holdings, said: “We are excited to partner with Catalent as it enters a new phase of growth and accelerates its mission to develop, manufacture and supply products that help people live better and healthier lives. With our expertise and track record of investing in high quality life sciences businesses, we believe Catalent is a very good strategic fit. We are excited to support the Company’s stakeholders in the years ahead, especially employees and customers as they work to develop new products to benefit patients. As engaged investors committed to productive relationships with all our partners, we look forward to working with the Catalent team to realise the Company’s full potential.

Importantly, our acquisition of Catalent is aligned with our mandate to invest in high quality life sciences companies for the benefit of the Novo Nordisk Foundation’s mission and philanthropic causes.”

Marc Steinberg, Partner at Elliott Investment Management L.P., said: “As a significant investor in Catalent, Elliott fully supports the transaction announced today. We believe that this transaction, which is the culmination of a process led by the Strategic and Operational Review Committee of the Catalent Board, clearly maximizes value for Catalent stockholders. We commend Catalent’s Board and management team for delivering this outstanding outcome.”

Transaction Details

The merger is expected to close towards the end of calendar year 2024, subject to customary closing conditions, including approval by Catalent stockholders and receipt of required regulatory approvals. The transaction is not subject to any financing contingency.

Following an evaluation of possible value-maximizing alternatives, the Catalent Board unanimously determined that the transaction with Novo Holdings, which delivers a premium and certain cash value, is in the best interest of Catalent. Accordingly, the Catalent Board unanimously recommends that Catalent stockholders vote in favor of the merger.

In addition, Elliott Investment Management L.P. and certain of its affiliates have entered into a support agreement pursuant to which they have agreed to vote their shares of Catalent common stock in favor of the merger.

Following the closing of the merger, shares of Catalent will no longer trade on the New York Stock Exchange and Catalent will become a private company.

Second Quarter 2024 Financial Results

Catalent’s second quarter 2024 earnings results are expected to be issued on February 9, 2024. In light of the announced transaction, Catalent will not host an earnings conference call. Catalent’s second quarter 2024 earnings press release will be available on its investor relations website at http://investor.catalent.com .

Advisors

Citi and J.P. Morgan are acting as financial advisors to Catalent. Skadden, Arps, Slate, Meagher & Flom LLP is serving as legal advisor to Catalent and Jones Day is serving as legal advisor to the Catalent Board of Directors. Morgan Stanley is acting as financial advisor to Novo Holdings and Goodwin Procter LLP is serving as legal advisor to Novo Holdings.

About Novo Holdings

Novo Holdings is a holding and investment company that is responsible for managing the assets and the wealth of the Novo Nordisk Foundation. The purpose of Novo Holdings is to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation.

Wholly owned by the Novo Nordisk Foundation, Novo Holdings is the controlling shareholder of Novo Nordisk A/S and Novonesis A/S and manages an investment portfolio with a long-term return perspective. In addition to managing a broad portfolio of equities, bonds, real estate, infrastructure and private equity assets, Novo Holdings is a world-leading life sciences investor. Through its Seeds, Venture, Growth, and Principal Investments teams, Novo Holdings invests in life science companies at all stages of development.

As of year-end 2022, Novo Holdings had total assets of EUR 108 billion.
www.novoholdings.dk

About the Novo Nordisk Foundation

Established in Denmark in 1924, the Novo Nordisk Foundation is an enterprise foundation with philanthropic objectives. The vision of the Foundation is to improve people’s health and the sustainability of society and the planet. The Foundation’s mission is to progress research and innovation in the prevention and treatment of cardiometabolic and infectious diseases as well as to advance knowledge and solutions to support a green transformation of society.
www.novonordiskfonden.dk/en

About Catalent

Catalent, Inc. is a global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent helps accelerate over 1,500 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply approximately 70 billion doses of nearly 8,000 products annually. Catalent’s expert workforce of nearly 18,000 includes more than 3,000 scientists and technicians. Headquartered in Somerset, New Jersey, the company generated nearly $4.3 billion in revenue in its 2023 fiscal year.
👍️0
Mt. Blanc Mt. Blanc 3 months ago
SNOW has been on a tear.

CTLT gets bought out.

mb
👍️0
Monksdream Monksdream 3 months ago
SNOW new 52=week high
👍️0
TheFinalCD TheFinalCD 8 months ago
SNOW NVDA
👍️0
BottomBounce BottomBounce 9 months ago
Snowflake Inc. $SNOW Total Debt (mrq) $254.84M
👍️0
alchemytrader alchemytrader 1 year ago
150.00 now...never say never.
👍️0
$Pistol Pete$ $Pistol Pete$ 1 year ago
Nice close man…I am heavy invest into this one
👍️0
$Pistol Pete$ $Pistol Pete$ 1 year ago
I don’t think it will get below $120 again. Maybe in our dream though
👍️0
alchemytrader alchemytrader 1 year ago
wait for 120.00 to be interested.
👍️0
$Pistol Pete$ $Pistol Pete$ 1 year ago
Buy the dip man
👍️0
$Pistol Pete$ $Pistol Pete$ 1 year ago
Holding strong here
👍️0
StockLogistics StockLogistics 2 years ago
This stock is called “snow” and SP increases from May till early December, before winter begins in the U.S.., it appears. That is some sort of counter trend to the idea of snowing.
👍️0
Liam859 Liam859 2 years ago
$SNOW $128 I loaded so you can dump on me now
👍️0
alchemytrader alchemytrader 2 years ago
Calls babyyyy$$$$


OMG...RIP!
👍️0
alchemytrader alchemytrader 2 years ago
SNOW melted again.
👍️0
Porterhouse10 Porterhouse10 2 years ago
Down goes Balboa! Yo Adrian!
👍️0
Porterhouse10 Porterhouse10 2 years ago
It just Did!
👍️0
bcapps66 bcapps66 2 years ago
Looking at the price drop the last few days that should have read "CRIES babyyyy" LOL!
👍️0
IVANj IVANj 2 years ago
Calls babyyyy$$$$
👍️0
bcapps66 bcapps66 2 years ago
Wow! Just...wow
👍️0
bcapps66 bcapps66 2 years ago
Ouch!!! Wicked haircut!
👍️0
Prudent Capitalist Prudent Capitalist 2 years ago
If increasing revenue by 101% over the previous comparable quarter and improving the bottom line is bad, then Houston, we have a problem. It appears that the problem was disappointing forward guidance that did not match Wall Street expectations. SNOW is a screaming buy down here for long term investors, e.g. this am Cowen & Co. maintained its outperform rating but lowered its price target for SNOW to $390. Several firms still have price targets in the high $300's for SNOW, even after adjustments since the release last evening. I sure wouldn't sell any SNOW shares down here.
👍️0
alchemytrader alchemytrader 2 years ago
WOW! -30% drop after hours on bad earnings!
👍️0
ThatHawaiiGuy ThatHawaiiGuy 3 years ago
WOW! +50% since i started watching this bad dog....
👍️0
BottomBounce BottomBounce 3 years ago
$SNOW Total Debt (mrq) $200.53M
Book Value Per Share (mrq) $16.76
https://finance.yahoo.com/quote/SNOW/key-statistics?p=SNOW
👍️0
WealthyKing WealthyKing 3 years ago
Come on snow! 100 calls @240 expiring today ...
👍️0
WealthyKing WealthyKing 3 years ago
I was 5 days off on my ask for $270, too bad I was holding such near term options that went worthless...thanks for the reminder
👍️0
Reversemergers Reversemergers 3 years ago
I want 270 tomorrow too
👍️0
Nunngoy Nunngoy 3 years ago
King -- sorry for the loss - nobody else has the B ____S to admit it - GET IT BACK !
👍️0
Nunngoy Nunngoy 3 years ago
King -- sorry for the loss - nobody else has the B ____S to admit it - GET IT BACK !
👍️0
WealthyKing WealthyKing 3 years ago
And back down $snow goes. Can we please see 270 tomorrow
👍️0
WealthyKing WealthyKing 3 years ago
Snow may be bucking the trend here, time to move back up
👍️0
TheSprinx TheSprinx 3 years ago
Snowflake Data Marketplace Expands Total Providers Over 300%, Unlocking More Value for Thousands of Organizations!!!!
Boom
👍️0
WealthyKing WealthyKing 3 years ago
I'd love to see them dump 15 million today or tomorrow
👍️0
zatafour zatafour 3 years ago
SNOW... loading up puts, the locked up shares are in the process of being cleared by brokers
👍️0
WealthyKing WealthyKing 3 years ago
Sold my call options for loss yesterday thinking today would be big red day...this sucks
👍️0
WealthyKing WealthyKing 3 years ago
My put options went from big green to 95% loss today...friggin bs
👍️0
Pisd Pisd 3 years ago
Made money.. sold remaining shares today ..watch list SNOW$...



👍️0
WealthyKing WealthyKing 3 years ago
What a bunch of bs today...
👍️0
Pisd Pisd 3 years ago
Snowflake Lockup to End Early for Some Shares. A Blizzard of Selling Is Possible. -- Barrons.com

Today 2:22 PM ET (Dow Jones)Print


By Eric J. Savitz

Snowflake could be headed for an avalanche of insider selling.

In a securities filing late last week, the cloud-based data warehouse company disclosed that the huge run-up in its stock price following its initial public offering had triggered a provision in its lockup agreement with the company's officers, directors, and early shareholders to allow a quarter of those holdings to trade.

Terms of the deal required that Snowflake (ticker: SNOW) trade 133% above the company's $120 IPO price for at least 10 days in a 15-day period. That requirement was fulfilled on Dec. 29, and 37.9 million previously locked-up Snowflake shares will be free to trade on Thursday.

Note that the company issued 28 million shares in its September IPO. An initial tranche of previously locked-up stock became free-trading on Dec. 15.

Snowflake shares, while still well above the original IPO price, have come back a little closer to terra firma. The stock opened for trading on Sept. 16 at $245, then closed at $253.93. As recently as a month ago, the stock traded as high as $429 on an intraday basis, but it has since been gradually ebbing, closing on Monday at $278.24.

Snowflake has slipped about 14% since the first tranche of insider shares was freed up for trading.

In a research note Tuesday, Deutsche Bank analyst Patrick Colville repeated his Hold rating, cutting his price target on the stock to $335, from $270. He estimates that the additional shares to be freed this week will increase the free float in Snowflake shares by 87%.

"With Snowflake stock up almost 133% from its IPO price, we expect some investors to cash out as lockups expire," he wrote. "This could weigh on share price accretion from here."


But in trading Tuesday, Snowflake was actually up 1.6%, to $282.74.


Write to Eric J. Savitz at eric.savitz@barrons.com

(END) Dow Jones Newswires

January 05, 2021 14:22 ET (19:22 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
👍️0
Pisd Pisd 3 years ago
Doubled down here $292, might hold on.. SNOW$...


👍️0
Pisd Pisd 3 years ago
Made money two swing trades..try again today imo.. SNOW$...



👍️0
ClayTrader ClayTrader 3 years ago
* * $SNOW Video Chart 12-15-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
Pisd Pisd 3 years ago
Too soon lol ..
👍️0

Your Recent History

Delayed Upgrade Clock